FDA Clears First AI-ECG Screening Tools for CV Care: What's Next Is Up for Grabs

These first “SAMDs” leverage ECGs to pick up worsening EF and hypertrophic cardiomyopathy, but more loom on the horizon.

Related Keywords

Tufts Medical Center ,Massachusetts ,United States ,Boston ,American ,Los Angeles ,Paul Friedman ,David Ouyang ,Mitchell Psotka ,Jayme Strauss ,American Heart Association ,Falls Church ,Bristol Myers Squibb ,Vascular Institute ,European Society Of Cardiology Congress ,Sinai Medical Center ,Drug Administration ,International Medical Device Regulators Forum ,Md Smidt Heart Institute ,Mayo Clinic ,Inova Heart ,Smidt Heart Institute ,Cedars Sinai Medical Center ,Amanda Vest ,Bristol Myers ,Scientific Sessions ,European Society ,Cardiology Congress ,